 Response rates relapsed Wilms tumor need new effective agents eighty-one children Wilms tumor United Kingdom Children Cancer Study Group Study Seventy-one patients relapses treatment surgery chemotherapy radiation therapy stage histologic characteristics Forty-nine patients evaluable disease response second-line chemotherapy Evaluation response chemotherapy impossible patients surgery radiation therapy time relapse second-line combination chemotherapy ifosfamide cisplatin/carboplatin bleomycin melphalan Thiotepa Lederle Pearl River NY complete responses partial responses patients favorable histologic findings Stage ten Stage II none Stage III Stage IV Stage disease survivors chemotherapy others combined treatment chemotherapy radiation therapy and/or surgery unfavorable histologic findings stage authors patients localized disease favorable histologic findings salvage rate stages histologic findings likelihood cure relapse remote need additional effective chemotherapeutic agents patients